RNS Number : 3174F
PureTech Health PLC
13 November 2020
PureTech Health plc (the "Company")
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility or their Connected Persons
In connection with the listing of the Company's American Depository Shares ("ADS's") on the Nasdaq Global Market and in order to satisfy Nasdaq listing rules, on 11 November 2020, (i) the Zohar Family Trust I, of which Ms. Daphne Zohar (the Chief Executive Officer and a Director of the Company) is a trustee and beneficiary, converted 2,050,000 Ordinary Shares in the Company to ADS's in line with the ratio of 10 ordinary shares to per one ADS and (ii) the Zohar Family Trust II, of which Ms. Daphne Zohar (the Chief Executive Officer and a Director of the Company) is a trustee and beneficiary, converted 2,050,000 Ordinary Shares in the Company to ADS's in line with the ratio of 10 ordinary shares to one ADS.
The foregoing is a notifiable transaction but does not involve any disposal of such interest. Following this transaction, Ms. Zohar continues to have a direct and indirect interest in 12,197,307 Ordinary Shares, representing approximately 4.3% of the issued share capital of the Company. No Ordinary Shares or ADS's are being sold or disposed of by Ms. Zohar or her related entities in connection with the Nasdaq listing.
This notification is made under Article 19 of the Market Abuse Regulation.
PDMR DEALING NOTIFICATION
|
1
|
Details of the person discharging managerial responsibilities/person closely associated
|
|
a)
|
Name
|
The Zohar Family Trust I and The Zohar Family Trust II
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Ms. Daphne Zohar, the Chief Executive Officer and a Director, is a Trustee of the above listed Trusts
|
|
b)
|
Initial notification/Amendment
|
Initial
notification
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
PureTech Health plc
|
|
b)
|
LEI
|
213800LVPDNO2Z9T9I39
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
|
Ordinary shares of PureTech Health plc
|
|
ISIN GB00BY2Z0H74
|
|
b)
|
Nature of the transaction
|
Conversion by the Zohar Family Trust I of 2,050,000 Ordinary Shares into 205,000 American Depository Shares for nil consideration and conversion by the Zohar Family Trust II of 2,050,000 Ordinary Shares into 205,000 American Depository Shares for nil consideration.
|
|
c)
|
Price(s) and volume(s)
|
|
|
Price(s)
|
Volume(s)
|
|
Zohar Family Trust I
|
Nil
|
2,050,000 Ordinary Shares converting into 205,000 ADS's
|
|
Zohar Family Trust II
|
Nil
|
2,050,000 Ordinary Shares converting into 205,000 ADS's
|
|
|
d)
|
Aggregated information
|
|
Price
|
Aggregate Volume
|
|
n/a
|
n/a
|
|
|
e)
|
Date of the transaction
|
11 November 2020
|
|
f)
|
Place of the transaction
|
Outside of a trading venue
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
DSHZXLFFBFLLFBK
|
